NCT07175220 2025-11-18Phase II Clinical Study of SHR2554 Tablets Combined With Other Anti-tumor Treatments in Non-small Cell Lung Cancer SubjectsJiangsu HengRui Medicine Co., Ltd.Phase 2 Recruiting200 enrolled